Clinical Trials Directory

Trials / Completed

CompletedNCT02987556

Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7)

Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop for Three Months at Home in Comparison With Conventional Treatment by External Insulin Pump in Patients With Type 1 Diabetes.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study will be conducted in crossover trial, with two 12-weeks periods separated by a Wash-out period of at least one month. According to randomization ,patients will be provided with either Diabeloop system or the usual system. Patients will be trained for the use of blood glucose meter, of external Insulin Pump and Diabeloop system. In both treatment periods, the same blood glucose meter will be used throughout the duration of the study. In two centers (Centre Hospitalier Sud-Francilien and Grenoble), a pre-study will be performed during four weeks to improve the efficacy of Diabeloop system with data collection, to test the manual settings by health care providers and patients and to check the good-working of the follow-up platform.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous Glucose MonitoringCollection of glucose data
DEVICEExternal Insulin Pumpinsulin delivery
OTHERtelemdecineRemote follow up by care health providers team
DEVICEThe Diabeloop Software (Model predictive control)Diabeloop is a Closed-loop (CL) system with a Model Predictive Control (MPC) algorithm reinforced by a decisional matrix, uploaded on a dedicated android smartphone linked to Dexcom CGM and a Cellnovo or Kaleido insulin patch-pump. The Diabeloop software calculates the insulin dose according to the patient's needs.

Timeline

Start date
2017-03-30
Primary completion
2018-08-28
Completion
2018-08-28
First posted
2016-12-09
Last updated
2019-02-01

Locations

12 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02987556. Inclusion in this directory is not an endorsement.